Romans 12:19
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
..you can't win if you don't play..
$RLFTF Really good presentation .. Great 20 min. on Aviptadil and the 21 Patients.
Aviptadil (RLF-100) For COVID-19: 21 Patients With Severe Refractory COVID Showing Improvements!
maybe everything that's happening is intentional.. to what end and in who's favor ?? mhh.. OTC Casino ..somebody comp me a drink man !!!
$RLFTF RELIEF THERAPEUTICS HOLDING SA Announces Plans to Test Aviptadil for Treatment of COVID-induced Acute Respiratory Distress Syndrome https://infomeddnews.com/relief-therapeutics-holding-sa-announces-plans-to-test-aviptadil-for-treatment-of-covid-induced-acute-respiratory-distress-syndrome/
Update: 8/28 AM
No x-rays today yet. Vent is still on 40% but ECMO is now at 95%. All labs and blood pressure are “great”.
"The difference between Covid-19 and a mild head cold is the ability of the Covid-19 virus to attack alveolar cells in the lung, Javitt said.
“It invades the cells and makes a million copies of itself,” he said. “It stops the production of surfaxin in the lungs, and if you can’t make surfaxin (a lubricant essential for breathing) you can’t oxygenate your blood.”
Oxygenated blood is needed for the body to function properly.
The RLF-100 polypeptide, Javitt said, has demonstrated an ability to protect the alveolar cells in the lung.
Many of the therapeutics being developed to treat respiratory distress syndrome in Covid-19 patients, he said, are designed to act like a sponge and soak up cytokines in the body. RLF-100 is being developed to block the inflammatory cytokines from being produced, he said.
“Would you rather use a sponge to mop up spilled milk, or not spill the milk in the first place?” Javitt asked. "
https://www.bizjournals.com/philadelphia/news/2020/08/27/target-covid-19-philadelphia-companies-vaccines.html
..maybe people should just stay in their lane and mind their own trading.. these posts about others are also a waste of energy.. no?
..yes I know.. I buy NASDQ, AMEX and DOW also.. didn't really want to get into it.. but yeah look at all the trading programs, new traders.. etc.. so much is going on that's new as you know..
..couple good flips were to be had here last few weeks.. not sure if they're weak hands or active traders making bank?
..I've held.. but in the future I'll be paying more attention to the way these traders work.. the market/trading mentality has changed so much, so many new momentum, robinhood and video gamers w/ADD move prices in a whole new way IMO
Florida Sees Nearly 9,000 New COVID-19 Cases Among Children As Schools Reopen https://www.ibtimes.com/florida-sees-nearly-9000-new-covid-19-cases-among-children-schools-reopen-3035168
Still not confirmed - RLFTF NOW TRADING ON London and Germany stock exchanges.
Still not confirmed - RLFTF NOW TRADING ON London and Germany stock exchanges.
$RLFTF NOW TRADING ON London and Germany stock exchanges.
$RLFTF NOW TRADING ON London and Germany stock exchanges.
..someone mentioned the vent% changes could also help to exercise the lungs.. and they will build 'em up slowly.. but I didn't confirm this w/the people in the know ..
Update: 8/26 AM
No real changes. We’re basically in a wait it out phase. Changes will be very slow or none at all some days. Currently the vent is set at 50% and ECMO still at 100%. Blood pressure is steady and holding its own.
Gotta get some Relief Man !!
"RIGHT TO TRY" ..a few solid therapeutic companies seem to be having deep volcanic boils.. maybe it's the plasma thing not being that effective, other well knowns not being in the sights of big gov.$$ support.. but there are a few heating up and I think people are nervous and are really paying attention to scientific results now.. and Relief Therapeutics is one of them.. this story is getting real.
P.S. Texas is preparing.. updates may slow..
Great point!! Great quotes from the article.
“No doubt the White House has taken notice and with the upcoming election and Trump needing a win, we could see emergency fast-track approval under Operation Warp Speed along with federal funding for RLF-100. For all these reasons, we believe RLFTF stock is the best COVID-19 bet right now.”
https://insiderfinancial.com/rlftf-stock-best-covid-19-bet/180308/
$RLFTF Why RLFTF Stock Is The Best COVID-19 Bet - https://insiderfinancial.com/rlftf-stock-best-covid-19-bet/180308/
More reports confirm that coronavirus reinfection is possible https://bgr.com/2020/08/25/coronavirus-reinfection-confirmed-hong-kong-belgium-netherlands/
..same people who were dropping this down will run it back up soon enough.. they don't wanna get caught by the PR's they know are coming.. nice to be on the inside making money Elevator style..
$RLFTF RLF-100 Patient story. Haven't seen this before on NeuroRX website.
https://www.neurorxpharma.com/patientstories/
$RLFTF Lots of surprise COVID-19 News conferences coming IMO
..took a hit !! ;)
Searcy case write up link..
https://www.facebook.com/photo?fbid=2871311279639859&set=gm.1468252816718487
Matthew Freeze
Credit:
like many, I am rooting for #RLF100 and $RLFTF. This drug has great promise for patients who are otherwise nearing end of life. I also believe the science shows great promise for early-stage treatment (inhalant). We must remember the facts (thread):
— blockchainVibes (@BlockchainVibes) August 25, 2020
$RVVTF Revive Therapeutics (RVV.C): Kicked around, called a fraud, gets FDA approval of Phase 3 COVID-19 trials
https://www.google.com/amp/s/equity.guru/2020/04/23/revive-therapeutics-rvv-c-kicked-around-called-fraud-gets-fda-approval-phase-iii-covid-19-trials/amp/
$RLFTF UPGRADED TO OTCQB AND WILL BE MADE FILINGS WITH SEC TOO.
https://sec.report/otc/financial-report/256107
..yeah that whole plasma thing was a curve ball to deflect.. something is brewing..
4sure $$$ ..this thing hasn't even started yet.. GROUND FLOOR
$RLFTF Uncle Gee Gee (CopyDD)
Summary of known facts about RLFTF: Aviptadil RLF-100 VIP
• Aviptadil is a repurposed erectile dysfunction drug, proven to be safe since 1970’s.
• Aviptadil blocks Covid from attaching to host cells in the lungs, prevents the cytokine storm, and reduces inflammation. This is a targeted trifecta for treating Covid.
• An inhaler version of Aviptadil will undergo clinical trials, with the intent to ultimately be used for in-home treatment of Covid cases. This study is expected to complete around Nov 31, with results being published sometime afterwards.
• Aviptadil is inexpensive and easy to manufacture.
• Aviptadil shows promise for other lung applications beyond Covid, which also needs to be studied and tested.
Stock/Company
• Relief Therapeutics holds the patent on Aviptadil. It is a small company in Switzerland, traded over the counter (OTC).
• NeuroRX is a private US-based partner with leadership that is well-connected at the highest levels of government and big pharma. They are guiding Relief Therapeutics through the FDA approval process.
• Company has $3M cash, but will need approx. another $20M to complete all 3 trials, including inhaler version.
• Unconfirmed: Most of the outstanding shares are owned by insiders.
• Chairman Raghuram (Ram) Selvaraju says there is no real need to raise capital via additional shares at this point, due to liquidity option provided by GEM.
• Speculation: Company may have recently raised enough additional capital to complete trials through Princeton Angels.
Manufacturing and Distribution
• Robert Bestoff, Chief of Operations, spent his career at Lilly & Pfizer. At Pfizer, he was head of entire neuro science and pain division and was responsible for $10b of drugs.
• Manufacturing program put together by Rich Siegel, former head of Johnson & Johnson’s drug portfolio.
• 2 Partnership arrangements are expected to be announced soon.
• “We are about to announce a partnership with the largest supplier of inhaled sterile drugs in the United States.” NeuroRX CEO Dr. Javitt
• “We are about to announce a partnership with a very large well-known public company that can get any drug to any hospital overnight” NeuroRX CEO Dr. Javitt
• “By October, we should be manufacturing enough drug for 100,000 people each month.” NeuroRX CEO Dr. Javitt
Clinical Trials
• Clinical Trial NCT04311697 – The initial clinical trial underway to test intravenously administered drug. Approximately 86 out of 122 patients have been recruited as of Aug 12, and the company’s data committee will begin reviewing the cases once they reach 102 patients. From there, they will present findings to the FDA. Speculation: Review could begin this week of 8/24; however, official publication of results could take several more weeks, but likely before October, due to Javitt’s comments about being able to ramp up production by October.
• Clinical Trial NCT04453839 – The FDA-approved Expanded Access program for treating patients who are too sick for clinical trials.
• Expanded Access results were released in a “pre-print” document, showing 19 of 21 patients have survived. These are the sickest of the sick (ICU, ventilators, ECMO patients). The pre-print is under peer review & expected to be officially released in the coming weeks.
• Clinical Trial NCT04360096 – A study of 288 patients to test an inhaler-version of RLF-100, intended to ultimately be used for in-home treatments. Estimated completion of trial is November 30th. According to Dr. Javitt: “We expect that half the people we enroll in our inhaled study are going to be people who are outpatients.”
$RLFTF Really good presentation .. Great 20 min. on Aviptadil and the 21 Patients.
Aviptadil (RLF-100) For COVID-19: 21 Patients With Severe Refractory COVID Showing Improvements!
FDA Walks Back Claim of Dramatic Benefit From Covid Therapy http://a.msn.com/05/en-us/BB18k6ht?ocid=st
"everyone knows" No not everyone.. go easy leaf
Zoom had problems and shut down in various parts during school openings ?
FDA Walks Back Claim of Dramatic Benefit From Covid Therapy http://a.msn.com/05/en-us/BB18k6ht?ocid=st
JB - Thank you
$RLFTF Old news is still Good news -RLF-100 (aviptadil) clinical trial showed rapid recovery from respiratory failure and inhibition ... https://finance.yahoo.com/news/rlf-100-aviptadil-clinical-trial-200000564.html?soc_src=social-sh&soc_trk=tw via @YahooFinance
I'm seeing lots of new people investing.. I mean brand new.. and I relived those old emotional swings and learning curves of the early days while answering some questions.. it's easy to be tolerant when we remember when we had to pay our own dues..
Crazy World we live in...
" I'm a nurse. I will tell you that physicians will support this drug. Especially if they're getting positive results whether inside or outside the clinical trials. Its heartbreaking to see a patient die due to lack of effective drugs. I just hope that the FDA doesn't slow down the approval process. This isn't the time for politics!......"
First Case of COVID-19 Reinfection Confirmed https://www.medpagetoday.com/infectiousdisease/covid19/88234